Wave Life Sciences Ltd. financial data

Symbol
WVE on Nasdaq
Location
7 Straits View, #12 00, Marina One East Tower, Singapore, Singapore
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 274 % +105%
Debt-to-equity 70.9 % -82.9%
Return On Equity -75.6 % +73.1%
Return On Assets -43 % +18.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 167M shares +9.61%
Common Stock, Shares, Outstanding 160M shares +8.02%
Entity Public Float 489M USD +88.9%
Common Stock, Value, Issued 1.22B USD +7.37%
Weighted Average Number of Shares Outstanding, Basic 168M shares +26.5%
Weighted Average Number of Shares Outstanding, Diluted 168M shares +26.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 8.7M USD -55.8%
Research and Development Expense 175M USD +17.1%
General and Administrative Expense 70.6M USD +24.8%
Operating Income (Loss) -136M USD +10.6%
Nonoperating Income (Expense) 14M USD +46.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -122M USD +14.4%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -122M USD +14.4%
Earnings Per Share, Basic 0 USD/shares +40%
Earnings Per Share, Diluted 0 USD/shares +40%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 196M USD -36.9%
Accounts Receivable, after Allowance for Credit Loss, Current 10M USD
Other Assets, Current 2.62M USD -12.6%
Assets, Current 215M USD -33.6%
Property, Plant and Equipment, Net 8.2M USD -25%
Operating Lease, Right-of-Use Asset 13.9M USD -27.4%
Other Assets, Noncurrent 22K USD
Assets 241M USD -32.7%
Accounts Payable, Current 14.5M USD +13.4%
Employee-related Liabilities, Current 11.1M USD +14.4%
Accrued Liabilities, Current 4.59M USD +62.5%
Contract with Customer, Liability, Current 46.5M USD -65.8%
Liabilities, Current 85.9M USD -49.7%
Contract with Customer, Liability, Noncurrent 11.7M USD -36.8%
Operating Lease, Liability, Noncurrent 11.4M USD -42.5%
Other Liabilities, Noncurrent 190K USD
Liabilities 109M USD -47.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -190K USD -19.5%
Retained Earnings (Accumulated Deficit) -1.27B USD -10.6%
Stockholders' Equity Attributable to Parent 125M USD -12.1%
Liabilities and Equity 241M USD -32.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -63M USD -88.6%
Net Cash Provided by (Used in) Financing Activities 4.16M USD -71.4%
Net Cash Provided by (Used in) Investing Activities -165K USD +60.4%
Common Stock, Shares, Issued 160M shares +8.02%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -59M USD -204%
Deferred Tax Assets, Valuation Allowance 272M USD +10.2%
Deferred Tax Assets, Gross 277M USD +9.31%
Operating Lease, Liability 25.4M USD -20.9%
Depreciation 875K USD -16%
Payments to Acquire Property, Plant, and Equipment 165K USD -60.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -122M USD +14.4%
Lessee, Operating Lease, Liability, to be Paid 29M USD -24.3%
Property, Plant and Equipment, Gross 56.5M USD +1.19%
Operating Lease, Liability, Current 8.39M USD +13.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.58M USD -0.07%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.59M USD +3.01%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.64M USD -41.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.99M USD -6.23%
Deferred Tax Assets, Operating Loss Carryforwards 178M USD +2.95%
Unrecognized Tax Benefits 20.8M USD +31.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 886K USD -90.1%
Additional Paid in Capital 174M USD +13.6%
Deferred Tax Assets, Net of Valuation Allowance 4.67M USD -24.6%
Share-based Payment Arrangement, Expense 4.95M USD +71.9%